Scilex Holding (SCLXW) Change in Inventory (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Change in Inventory of -$257000.0 in Q1 2026, up 49.51% quarter-over-quarter from -$509000.0 in Q4 2025, and down 144.01% on a YoY basis from $584000.0 in Q1 2025.

Scilex Holding (SCLXW) Change in Inventory (2022 - 2026) Analysis & Trends

Scilex Holding's Change in Inventory history runs 5 years deep, the most recent figure standing at -$257000.0 for Q1 2026.

  • In Q1 2026, Change in Inventory fell 144.01% year-over-year to -$257000.0; the TTM figure through Mar 2026 stood at -$2.6 million (down 1636.84% YoY), while the FY2025 annual figure was -$1.8 million, down 23.05% from the prior year.
  • Change in Inventory was -$257000.0 for Q1 2026 at Scilex Holding, up from -$509000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $897000.0 in Q1 2023 to a low of -$1.4 million in Q3 2025.
  • Historically, Change in Inventory has averaged -$109647.1 across 5 years, with a median of -$257000.0 in 2026.
  • The sharpest annual moves came in 2023 and 2025: Change in Inventory soared 466.96% in 2023, then plunged 1597.06% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $445000.0 in 2022, then plunged by 38.65% to $273000.0 in 2023, then slumped by 87.55% to $34000.0 in 2024, then slumped by 1597.06% to -$509000.0 in 2025, then soared by 49.51% to -$257000.0 in 2026.
  • The last three Change in Inventory figures came in at -$257000.0 (Q1 2026), -$509000.0 (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 431.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 184.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -18.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 52.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -14.00 Mn
10 Scilex Holding - - 4.15 Mn -257,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -257,000.00
Mar 31, 2026 -257,000.00
Dec 31, 2025 -509,000.00
Dec 31, 2025 -509,000.00
Sep 30, 2025 -1.38 Mn
Sep 30, 2025 -1.38 Mn
Jun 30, 2025 -496,000.00
Jun 30, 2025 -496,000.00
Mar 31, 2025 584,000.00
Mar 31, 2025 584,000.00
Dec 31, 2024 34,000.00
Dec 31, 2024 34,000.00
Sep 30, 2024 -358,000.00
Sep 30, 2024 -358,000.00
Jun 30, 2024 -412,000.00
Jun 30, 2024 -412,000.00
Mar 31, 2024 -726,000.00
Mar 31, 2024 -726,000.00
Dec 31, 2023 273,000.00
Dec 31, 2023 273,000.00